---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-098071"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2026-09-08T20:50:29+00:00"
generated_at: "2026-09-08T20:51:06.562293+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bluejay signs federal distribution deal with Lovell for SDVOSB set-aside markets

## Summary
- Exclusive SDVOSB set-aside distributor for VA, DoD, IHS procurements; non-exclusive rights on open-market federal/state/local deals.
- One-time $5,500 establishment fee paid; Lovell earns ~15% distribution fee on gross federal catalog sales plus 2% for DAPA prime vendor sales.
- Two-year initial term, auto-renewing annually unless 90-day notice; termination rights for default, bankruptcy, or $100K+ judgments.
- Deal signed Sep 1, 2026; press release Sep 8, 2026; partnership precedes FDA clearance, Symphony still investigational.
- Lovell provides access to VA FSS, GSA Advantage, MAS, ECAT, DAPA; co-marketing targets VHA ($165.1B FY2026 budget) and DoD/DHA ($64B).

## SEC filing metadata
- accession: 0001213900-26-098071
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2026-09-08T20:50:29+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390026098071/0001213900-26-098071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390026098071/ea0304864-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-098071
- JSON: https://secwatch.observer/filing/0001213900-26-098071.json
- Plain text: https://secwatch.observer/filing/0001213900-26-098071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.